ATX-GD-59 (1.6mg)

$75.00

Reconstitution Warranty Notice (Research Use Only)

For laboratory research use only. Not for human use.
Lyophilized peptides should be reconstituted using proper aseptic laboratory technique.
Reconstitution must be performed using Canlab-supplied Bacteriostatic Water and handled in
accordance with generally accepted research practices.
Warranty related to reconstitution, sterility, or material integrity applies only when Canlab
Bacteriostatic Water is used. Use of third-party diluents or deviation from provided handling
guidance voids any applicable warranty.
For full handling instructions and limitations, please refer to the Peptide Reconstitution,
Research Use Only section in our 

  Product Warranty Policy Page.

Description

Introducing ATX-GD-59, a cutting-edge peptide-based therapy meticulously crafted for the management of Graves’ disease. With a molecular weight of 2529.26 and a molecular formula of C114H198N32O32, ATX-GD-59 surpasses research-grade benchmarks, highlighting our unwavering dedication to excellence and pioneering advancements.

ATX-GD-59 redefines medical paradigms through its innovative mode of action, engineered to emulate epitopes and effectively immobilize the leukocytes responsible for assaulting the thyroid. It obstructs the generation of anti-thyroid stimulating hormone receptor (TSHR) stimulatory antibodies, revolutionizing the approach beyond conventional treatments. This advanced strategy homes in on the immunological foundation of Graves’ disease, marking a transformative path in disease management brought forth by ATX-GD-59.

VIP Member Access
Certain products are available exclusively to VIP members.
VIP membership is $79/year and provides access to restricted inventory.
DISCLAIMER
Products are sold for research use only.
Not for human or veterinary use. 
Information provided is not medical advice.